Holen Sie sich die Stockscreener-App
19.63
2.77%
0.53
Schlusskurs vom Vortag:
$19.10
Offen:
$19.38
24-Stunden-Volumen:
463.94K
Relative Volume:
0.61
Marktkapitalisierung:
$1.01B
Einnahmen:
$312.78M
Nettoeinkommen (Verlust:
$-143.56M
KGV:
-7.2974
EPS:
-2.69
Netto-Cashflow:
$1.22M
1W Leistung:
+0.82%
1M Leistung:
-2.77%
6M Leistung:
+61.83%
1J Leistung:
-20.97%
1-Tages-Spanne:
$19.31
$20.29
1-Wochen-Bereich:
$18.81
$21.00
52-Wochen-Spanne:
$10.96
$25.55
Caredx Inc Stock (CDNA) Company Profile
Firmenname
Caredx Inc
Sektor
Branche
Telefon
415-287-2300
Adresse
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
19.63 | 982.36M | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
504.82 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
212.58 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
629.35 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
125.81 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
323.37 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-06 | Herabstufung | Craig Hallum | Buy → Hold |
| 2025-08-26 | Eingeleitet | William Blair | Mkt Perform |
| 2025-01-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Underweight |
| 2024-08-19 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-05-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Hochstufung | Craig Hallum | Hold → Buy |
| 2023-11-09 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-03-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2023-03-03 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2021-07-20 | Fortgesetzt | BTIG Research | Buy |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-26 | Eingeleitet | BTIG Research | Buy |
| 2020-06-19 | Bestätigt | H.C. Wainwright | Buy |
| 2019-10-01 | Fortgesetzt | Craig Hallum | Buy |
| 2019-05-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Eingeleitet | Jefferies | Buy |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-09-18 | Bestätigt | H.C. Wainwright | Neutral |
| 2017-11-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-06-14 | Bestätigt | Mizuho | Buy |
| 2015-09-29 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Eingeleitet | Craig Hallum | Buy |
| 2015-03-18 | Bestätigt | Mizuho | Buy |
Alle ansehen
Caredx Inc Aktie (CDNA) Neueste Nachrichten
CareDx Seeks High Court Review Of $45M False Ad Case - Law360
CareDx Announces Clinical Validation Results for AlloHeme, the First AI-Powered NGS Surveillance Solution for AML and MDS Post-Cell Therapy - marketscreener.com
CareDx Expands “Transplant Plus” Into Cell Therapy, Showcases AlloHeme AML/MDS Relapse Data - MarketBeat
Page not foundAirwhon - MarketBeat
Panic Selling: Will CareDx Inc (1K9) stock benefit from infrastructure billQuarterly Trade Review & Risk Managed Investment Strategies - mfd.ru
CareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and MDS Post‑Cell Therapy - 01net
CareDx, Inc. $CDNA Stock Holdings Lessened by New York State Common Retirement Fund - MarketBeat
US Market Wrap: Whats the RSI of CareDx Inc stockJuly 2025 Movers & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - Yahoo Finance
CareDx, Inc. (NASDAQ:CDNA) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Insider Trends: What is the dividend yield of CareDx IncJuly 2025 Patterns & AI Enhanced Trading Alerts - baoquankhu1.vn
Liquidity Mapping Around (CDNA) Price Events - Stock Traders Daily
CareDx (NASDAQ:CDNA) Cut to "Hold" at Wall Street Zen - MarketBeat
Can CareDx (CDNA) Turn AlloHeme’s ACROBAT Data Into a Durable Precision-Transplant Moat? - simplywall.st
Lobbying Update: $15,000 of CAREDX lobbying was just disclosed - Quiver Quantitative
Short Covering: Can CareDx Inc keep up with sector leadersChart Signals & Free Reliable Trade Execution Plans - baoquankhu1.vn
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings - BioSpace
Momentum Shift: Will CareDx Inc stock benefit from M AWeekly Trend Summary & Reliable Volume Spike Alerts - baoquankhu1.vn
RSI Check: Will First Busey Corporation outperform small cap indexes2025 Price Targets & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Downgrade Watch: Will Quanex Building Products Corporation benefit from sector rotationMarket Risk Summary & Detailed Earnings Play Strategies - baoquankhu1.vn
Price Action: Does FDMT align with a passive investing strategyMarket Trend Review & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
CareDx CEO Sells Nearly 20,000 Shares in Open Market Transactions - Intellectia AI
CareDx's CEO Conducts Multiple Sale of Shares Towards the End of January 2026 - Yahoo Finance
CareDx's CEO Conducts Multiple Sale of Shares Towards the End of January 2026 - The Motley Fool
Did Strong 2025 Revenue Growth and 10x Genomics Deal Just Shift CareDx's (CDNA) Investment Narrative? - Yahoo Finance
CareDx President and CEO Sells 19,000 Shares for $412,000 - The Globe and Mail
CareDx, Inc. $CDNA is Gagnon Advisors LLC's 8th Largest Position - MarketBeat
CareDx, Inc. $CDNA Position Increased by Gagnon Securities LLC - MarketBeat
CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Chartmill
Can CareDx Inc deliver consistent dividendsDollar Strength & Advanced Swing Trade Entry Alerts - mfd.ru
Death Cross: Is CareDx Inc a play on infrastructure spendingCPI Data & AI Based Buy and Sell Signals - baoquankhu1.vn
Aug Update: Can CareDx Inc beat the S P 5002025 Volume Leaders & High Yield Equity Trading Tips - baoquankhu1.vn
Is CareDx’s Upgraded 2025 Revenue Outlook Altering The Investment Case For CareDx (CDNA)? - Sahm
CareDx CEO Hanna sells $412,222 in shares By Investing.com - Investing.com UK
CareDx CEO Hanna sells $412,222 in shares - Investing.com
Insider Sell: Hanna John Walter JR Sells Shares of CareDx Inc (C - GuruFocus
CareDx (NASDAQ:CDNA) CEO John Walter Hanna Jr Sells 19,280 Shares - MarketBeat
CareDx, Inc. (CDNA) Stock Analysis: A Healthcare Innovator With 4.66% Upside Potential - DirectorsTalk Interviews
CareDx (NASDAQ:CDNA) CEO John Walter Hanna Jr Sells 10,156 Shares - MarketBeat
Tech Rally: What is the dividend yield of CareDx IncJuly 2025 Analyst Calls & Risk Controlled Swing Alerts - baoquankhu1.vn
Sentiment Review: Can CareDx Inc generate free cash flow2025 Winners & Losers & Community Verified Trade Alerts - baoquankhu1.vn
Sumitomo Mitsui Trust Group Inc. Raises Stock Holdings in CareDx, Inc. $CDNA - MarketBeat
CareDx (CDNA) Is Up 19.5% After Stronger-Than-Expected 2025 Revenue GuidanceHas The Bull Case Changed? - Sahm
CareDx, Inc. (NASDAQ:CDNA) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
CareDx (CDNA) Valuation Check After Strong Preliminary 2025 Revenue Guidance And Transplant+ Pipeline Progress - Sahm
Can CareDx Inc maintain sales growthJuly 2025 Short Interest & Expert Curated Trade Setups - bollywoodhelpline.com
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Vertex Pharmaceuticals (VRTX) and CareDx (CDNA) - The Globe and Mail
Implied Volatility Surging for CareDx Stock Options - sharewise.com
CareDx (CDNA) Is Up 9.4% After Strong 2025 Outlook And 10x Genomics Tie-UpHas The Bull Case Changed? - Yahoo Finance
CareDx reports 25% revenue growth in Q4, expects $380 million for 2025 - Investing.com Canada
CareDx (NASDAQ:CDNA) Trading 15.3% HigherTime to Buy? - MarketBeat
Finanzdaten der Caredx Inc-Aktie (CDNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):